147 related articles for article (PubMed ID: 21497495)
1. The Korean Hereditary Breast Cancer (KOHBRA) study: protocols and interim report.
Han SA; Park SK; Ahn SH; Lee MH; Noh DY; Kim LS; Noh WC; Jung Y; Kim KS; Kim SW;
Clin Oncol (R Coll Radiol); 2011 Sep; 23(7):434-41. PubMed ID: 21497495
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: the Korean Hereditary Breast Cancer (KOHBRA) Study.
Son BH; Ahn SH; Kim SW; Kang E; Park SK; Lee MH; Noh WC; Kim LS; Jung Y; Kim KS; Noh DY; Moon BI; Suh YJ; Lee JE; Choi DH; Kim SY; Jung SH; Yom CK; Lee H; Yang JH;
Breast Cancer Res Treat; 2012 Jun; 133(3):1143-52. PubMed ID: 22382806
[TBL] [Abstract][Full Text] [Related]
3. The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study.
Kang E; Seong MW; Park SK; Lee JW; Lee J; Kim LS; Lee JE; Kim SY; Jeong J; Han SA; Kim SW;
Breast Cancer Res Treat; 2015 May; 151(1):157-68. PubMed ID: 25863477
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of BRCA mutations among familial breast cancer patients in Korea: results of the Korean Hereditary Breast Cancer study.
Han SA; Kim SW; Kang E; Park SK; Ahn SH; Lee MH; Nam SJ; Han W; Bae YT; Kim HA; Cho YU; Chang MC; Paik NS; Hwang KT; Kim SJ; Noh DY; Choi DH; Noh WC; Kim LS; Kim KS; Suh YJ; Lee JE; Jung Y; Moon BI; Yang JH; Son BH; Yom CK; Kim SY; Lee H; Jung SH;
Fam Cancer; 2013 Mar; 12(1):75-81. PubMed ID: 23131904
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and spectrum of BRCA1 and BRCA2 mutations in 3,922 Korean patients with breast and ovarian cancer.
Kim H; Cho DY; Choi DH; Choi SY; Shin I; Park W; Huh SJ; Han SH; Lee MH; Ahn SH; Son BH; Kim SW; ; Haffty BG
Breast Cancer Res Treat; 2012 Aug; 134(3):1315-26. PubMed ID: 22798144
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network.
Weitzel JN; Clague J; Martir-Negron A; Ogaz R; Herzog J; Ricker C; Jungbluth C; Cina C; Duncan P; Unzeitig G; Saldivar JS; Beattie M; Feldman N; Sand S; Port D; Barragan DI; John EM; Neuhausen SL; Larson GP
J Clin Oncol; 2013 Jan; 31(2):210-6. PubMed ID: 23233716
[TBL] [Abstract][Full Text] [Related]
7. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer.
Loman N; Johannsson O; Kristoffersson U; Olsson H; Borg A
J Natl Cancer Inst; 2001 Aug; 93(16):1215-23. PubMed ID: 11504767
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients.
Rashid MU; Zaidi A; Torres D; Sultan F; Benner A; Naqvi B; Shakoori AR; Seidel-Renkert A; Farooq H; Narod S; Amin A; Hamann U
Int J Cancer; 2006 Dec; 119(12):2832-9. PubMed ID: 16998791
[TBL] [Abstract][Full Text] [Related]
9. Dietary intake and breast cancer among carriers and noncarriers of BRCA mutations in the Korean Hereditary Breast Cancer Study.
Ko KP; Kim SW; Ma SH; Park B; Ahn Y; Lee JW; Lee MH; Kang E; Kim LS; Jung Y; Cho YU; Lee B; Lin JH; Park SK
Am J Clin Nutr; 2013 Dec; 98(6):1493-501. PubMed ID: 24153343
[TBL] [Abstract][Full Text] [Related]
10. Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing.
de la Hoya M; Osorio A; Godino J; Sulleiro S; Tosar A; Perez-Segura P; Fernandez C; Rodríguez R; Díaz-Rubio E; Benítez J; Devilee P; Caldés T
Int J Cancer; 2002 Feb; 97(4):466-71. PubMed ID: 11802208
[TBL] [Abstract][Full Text] [Related]
11. A population-based assessment of the clustering of breast cancer in families eligible for testing of BRCA1 and BRCA2 mutations.
Lorenzo Bermejo J; Hemminki K
Ann Oncol; 2005 Feb; 16(2):322-9. PubMed ID: 15668291
[TBL] [Abstract][Full Text] [Related]
12. KOHBRA BRCA risk calculator (KOHCal): a model for predicting BRCA1 and BRCA2 mutations in Korean breast cancer patients.
Kang E; Park SK; Lee JW; Kim Z; Noh WC; Jung Y; Yang JH; Jung SH; Kim SW
J Hum Genet; 2016 May; 61(5):365-71. PubMed ID: 26763880
[TBL] [Abstract][Full Text] [Related]
13. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.
de Juan I; Palanca S; Domenech A; Feliubadaló L; Segura Á; Osorio A; Chirivella I; de la Hoya M; Sánchez AB; Infante M; Tena I; Díez O; Garcia-Casado Z; Vega A; Teulé À; Barroso A; Pérez P; Durán M; Carrasco E; Juan-Fita MJ; Murria R; Llop M; Barragan E; Izquierdo Á; Benítez J; Caldés T; Salas D; Bolufer P
Fam Cancer; 2015 Dec; 14(4):505-13. PubMed ID: 26026974
[TBL] [Abstract][Full Text] [Related]
15. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
Berry DA; Iversen ES; Gudbjartsson DF; Hiller EH; Garber JE; Peshkin BN; Lerman C; Watson P; Lynch HT; Hilsenbeck SG; Rubinstein WS; Hughes KS; Parmigiani G
J Clin Oncol; 2002 Jun; 20(11):2701-12. PubMed ID: 12039933
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 and BRCA2 mutations in women with familial or early-onset breast/ovarian cancer in the Czech Republic.
Foretova L; Machackova E; Navratilova M; Pavlu H; Hruba M; Lukesova M; Valik D
Hum Mutat; 2004 Apr; 23(4):397-8. PubMed ID: 15024741
[TBL] [Abstract][Full Text] [Related]
17. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.
Risch HA; McLaughlin JR; Cole DE; Rosen B; Bradley L; Fan I; Tang J; Li S; Zhang S; Shaw PA; Narod SA
J Natl Cancer Inst; 2006 Dec; 98(23):1694-706. PubMed ID: 17148771
[TBL] [Abstract][Full Text] [Related]
18. BRCA and Breast Cancer-Related High-Penetrance Genes.
Han SA; Kim SW
Adv Exp Med Biol; 2021; 1187():473-490. PubMed ID: 33983595
[TBL] [Abstract][Full Text] [Related]
19. Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.
Giannini G; Capalbo C; Ristori E; Ricevuto E; Sidoni T; Buffone A; Cortesi E; Marchetti P; Scambia G; Tomao S; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A
Breast Cancer Res Treat; 2006 Nov; 100(1):83-91. PubMed ID: 16847550
[TBL] [Abstract][Full Text] [Related]
20. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
Fourati A; Louchez MM; Fournier J; Gamoudi A; Rahal K; El May MV; El May A; Revillion F; Peyrat JP
Bull Cancer; 2014 Nov; 101(11):E36-40. PubMed ID: 25418591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
